Miramontes Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Miramontes Capital's ABBV Position: Q3 2026 in Review
Miramontes Capital reduced its AbbVie (ABBV) stake by 0.68% in Q3 2026, selling an estimated $6.41K and leaving 3,643 shares worth $953K. The position accounts for 0.29% of the portfolio, ranked #52.
Miramontes Capital first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Miramontes Capital held 3,643 shares of AbbVie worth $953K as of Q3 2026.
- Miramontes Capital sold 25 AbbVie shares in Q3 2026, an estimated $6.41K.
- AbbVie made up 0.29% of Miramontes Capital's portfolio in Q3 2026, its #52 holding.
- Miramontes Capital first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Miramontes Capital's 13F filing for Q3 2026, filed 19 Oct 2026.